Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring ...
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...
Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a recent ...
Analysts at StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the stock. Trinity ...
How does the funding impact Trinity Biotech's CGM technology development? The new liquidity supports the ongoing development of Trinity Biotech’s innovative continuous glucose monitoring ...
“The additional liquidity will support critical initiatives, including the development of our CGM technology, and further positions Trinity Biotech for growth and profitability. Combined with ...
The study assessed the analytical performance of CGM technology enhancements implemented by Trinity Biotech since acquiring t -Metabolomics Diagnostics, a deep-tech machine learning diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback